BNP Paribas Financial Markets Acquires 92,498 Shares of The Clorox Company $CLX

BNP Paribas Financial Markets grew its holdings in shares of The Clorox Company (NYSE:CLX) by 51.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 271,245 shares of the company’s stock after purchasing an additional 92,498 shares during the quarter. BNP Paribas Financial Markets’ holdings in Clorox were worth $27,350,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of CLX. Norges Bank bought a new position in shares of Clorox during the 4th quarter valued at $135,735,000. Van ECK Associates Corp raised its holdings in shares of Clorox by 93.9% during the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock valued at $334,139,000 after purchasing an additional 1,312,471 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Clorox by 23.1% during the 3rd quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock valued at $492,656,000 after purchasing an additional 750,415 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Clorox by 6,907.9% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock valued at $75,593,000 after purchasing an additional 739,005 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC bought a new position in shares of Clorox during the 2nd quarter valued at $71,856,000. Institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling

In related news, Director Pierre R. Breber acquired 5,000 shares of the company’s stock in a transaction dated Tuesday, May 5th. The shares were bought at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director owned 18,000 shares in the company, valued at $1,544,760. This trade represents a 38.46% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.63% of the stock is owned by company insiders.

Clorox Stock Performance

Shares of CLX opened at $89.55 on Friday. The company has a market capitalization of $10.83 billion, a PE ratio of 14.54, a price-to-earnings-growth ratio of 0.46 and a beta of 0.56. The Clorox Company has a one year low of $84.70 and a one year high of $132.03. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The company’s fifty day moving average price is $97.16 and its 200 day moving average price is $105.39.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business’s quarterly revenue was up .1% on a year-over-year basis. During the same quarter last year, the firm posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, analysts expect that The Clorox Company will post 5.61 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on CLX. TD Cowen raised their price target on shares of Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a report on Tuesday, March 31st. Wells Fargo & Company cut their price target on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a report on Monday, May 18th. Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th. UBS Group dropped their target price on shares of Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Finally, Morgan Stanley dropped their target price on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. One analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have given a Sell rating to the company’s stock. Based on data from MarketBeat, Clorox presently has a consensus rating of “Reduce” and a consensus target price of $103.40.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.